MedPath

A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (prospective)

Not Applicable
Not yet recruiting
Conditions
Coronary heart disease
Registration Number
ITMCTR2023000064
Lead Sponsor
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Meeting the diagnostic criteria for coronary heart disease in Western medicine; (2) aged 18-85 years; and (3) signing an informed consent form.

Exclusion Criteria

(1) Patients with severe primary diseases such as combined hepatic and renal insufficiency, hematopoietic system abnormalities, and neurological diseases; (2) Pregnant or lactating women.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.